287 related articles for article (PubMed ID: 22699442)
21. Non-recombinant display of the B subunit of the heat labile toxin of Escherichia coli on wild type and mutant spores of Bacillus subtilis.
Isticato R; Sirec T; Treppiccione L; Maurano F; De Felice M; Rossi M; Ricca E
Microb Cell Fact; 2013 Oct; 12():98. PubMed ID: 24168229
[TBL] [Abstract][Full Text] [Related]
22. Systemic and local mucosal immune responses induced by orally delivered Bacillus subtilis spore expressing leucine aminopeptidase 2 of Clonorchis sinensis.
Qu H; Xu Y; Sun H; Lin J; Yu J; Tang Z; Shen J; Liang C; Li S; Chen W; Li X; Wu Z; Huang Y; Yu X
Parasitol Res; 2014 Aug; 113(8):3095-103. PubMed ID: 24906994
[TBL] [Abstract][Full Text] [Related]
23. The temperature of growth and sporulation modulates the efficiency of spore-display in Bacillus subtilis.
Petrillo C; Castaldi S; Lanzilli M; Saggese A; Donadio G; Baccigalupi L; Ricca E; Isticato R
Microb Cell Fact; 2020 Oct; 19(1):185. PubMed ID: 33004043
[TBL] [Abstract][Full Text] [Related]
24. The Bacterial Spore as a Mucosal Vaccine Delivery System.
Saggese A; Baccigalupi L; Donadio G; Ricca E; Isticato R
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446054
[TBL] [Abstract][Full Text] [Related]
25. Germination-Arrest
Sun R; Zhang M; Chen H; Wei Y; Ning D
Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33202570
[TBL] [Abstract][Full Text] [Related]
26. Polymeric penetration enhancers promote humoral immune responses to mucosal vaccines.
Klein K; Mann JF; Rogers P; Shattock RJ
J Control Release; 2014 Jun; 183():43-50. PubMed ID: 24657807
[TBL] [Abstract][Full Text] [Related]
27. Frequent nasal administrations of recombinant cholera toxin B subunit (rCTB)-containing tetanus and diphtheria toxoid vaccines induced antigen-specific serum and mucosal immune responses in the presence of anti-rCTB antibodies.
Yasuda Y; Isaka M; Taniguchi T; Zhao Y; Matano K; Matsui H; Morokuma K; Maeyama J; Ohkuma K; Goto N; Tochikubo K
Vaccine; 2003 Jun; 21(21-22):2954-63. PubMed ID: 12798639
[TBL] [Abstract][Full Text] [Related]
28. Gut adhesive Bacillus subtilis spores as a platform for mucosal delivery of antigens.
Tavares Batista M; Souza RD; Paccez JD; Luiz WB; Ferreira EL; Cavalcante RC; Ferreira RC; Ferreira LC
Infect Immun; 2014 Apr; 82(4):1414-23. PubMed ID: 24421038
[TBL] [Abstract][Full Text] [Related]
29. Bacillus subtilis comes of age as a vaccine production host and delivery vehicle.
Rosales-Mendoza S; Angulo C
Expert Rev Vaccines; 2015; 14(8):1135-48. PubMed ID: 26028252
[TBL] [Abstract][Full Text] [Related]
30. Oral vaccination of mice against tetanus with recombinant Lactococcus lactis.
Robinson K; Chamberlain LM; Schofield KM; Wells JM; Le Page RW
Nat Biotechnol; 1997 Jul; 15(7):653-7. PubMed ID: 9219268
[TBL] [Abstract][Full Text] [Related]
31. Mucosal immune responses induced by oral administration recombinant
Wang J; Huang L; Mou C; Zhang E; Wang Y; Cao Y; Yang Q
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30808716
[TBL] [Abstract][Full Text] [Related]
32. Surface Display of Antigen Protein VP8* of Porcine Rotavirus on
Li W; Feng J; Li J; Li J; Wang Z; Khalique A; Yang M; Ni X; Zeng D; Zhang D; Jing B; Luo Q; Pan K
Molecules; 2019 Oct; 24(20):. PubMed ID: 31652492
[TBL] [Abstract][Full Text] [Related]
33. Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit.
Isaka M; Yasuda Y; Kozuka S; Miura Y; Taniguchi T; Matano K; Goto N; Tochikubo K
Vaccine; 1998 Oct; 16(17):1620-6. PubMed ID: 9713937
[TBL] [Abstract][Full Text] [Related]
34. Progress in Bacillus subtilis Spore Surface Display Technology towards Environment, Vaccine Development, and Biocatalysis.
Chen H; Ullah J; Jia J
J Mol Microbiol Biotechnol; 2017; 27(3):159-167. PubMed ID: 28605732
[TBL] [Abstract][Full Text] [Related]
35. Oral delivery of Bacillus subtilis spores expressing cysteine protease of Clonorchis sinensis to grass carp (Ctenopharyngodon idellus): Induces immune responses and has no damage on liver and intestine function.
Tang Z; Sun H; Chen T; Lin Z; Jiang H; Zhou X; Shi C; Pan H; Chang O; Ren P; Yu J; Li X; Xu J; Huang Y; Yu X
Fish Shellfish Immunol; 2017 May; 64():287-296. PubMed ID: 28323213
[TBL] [Abstract][Full Text] [Related]
36. Enhanced immunisation and expression strategies using bacterial spores as heat-stable vaccine delivery vehicles.
Uyen NQ; Hong HA; Cutting SM
Vaccine; 2007 Jan; 25(2):356-65. PubMed ID: 16920233
[TBL] [Abstract][Full Text] [Related]
37. Mucosal Delivery of Fusion Proteins with
Copland A; Diogo GR; Hart P; Harris S; Tran AC; Paul MJ; Singh M; Cutting SM; Reljic R
Front Immunol; 2018; 9():346. PubMed ID: 29593708
[TBL] [Abstract][Full Text] [Related]
38. Oral priming of mice by recombinant spores of Bacillus subtilis.
Ciabattini A; Parigi R; Isticato R; Oggioni MR; Pozzi G
Vaccine; 2004 Oct; 22(31-32):4139-43. PubMed ID: 15474704
[TBL] [Abstract][Full Text] [Related]
39. Recombinant Bacillus subtilis spores expressing cholera toxin B subunit and Helicobacter pylori urease B confer protection against H. pylori in mice.
Zhou Z; Dong H; Huang Y; Yao S; Liang B; Xie Y; Long Y; Mai J; Gong S
J Med Microbiol; 2017 Jan; 66(1):83-89. PubMed ID: 27930268
[TBL] [Abstract][Full Text] [Related]
40. Mucosal Immunization with Spore-Based Vaccines against
Uddin MS; Kaldis A; Menassa R; Ortiz Guluarte J; Barreda DR; Guan LL; Alexander TW
Vaccines (Basel); 2024 Apr; 12(4):. PubMed ID: 38675757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
